Covid-19 Impact on Global Innovative Drug Market Size, Status and Forecast 2020-2026

June 2020 | 133 pages | ID: CFBB6FC7578BEN
QYResearch

Abstracts

This report focuses on the global Innovative Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Innovative Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Roche
• Sanofi
• Johnson & Johnson
• Merck & Co. (MSD)
• Novartis
• AbbVie
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly
• Teva
• Bayer
• Novo Nordisk
• Allergan
• Takeda
• Boehringer Ingelheim

Market segment by Type, the product can be split into

• Biological Medicine
• Chemical Medicine

Market segment by Application, split into

• Hospitals and Clinics
• Pharmacy
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Innovative Drug status, future forecast, growth opportunity, key market and key players.
• To present the Innovative Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Innovative Drug are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Innovative Drug Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Innovative Drug Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Biological Medicine
  1.4.3 Chemical Medicine
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Innovative Drug Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Pharmacy
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Innovative Drug Industry Impact
  1.6.1 How the Covid-19 is Affecting the Innovative Drug Industry
    1.6.1.1 Innovative Drug Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Innovative Drug Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Innovative Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Innovative Drug Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Innovative Drug Growth Trends by Regions
  2.2.1 Innovative Drug Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Innovative Drug Historic Market Share by Regions (2015-2020)
  2.2.3 Innovative Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Innovative Drug Market Growth Strategy
  2.3.6 Primary Interviews with Key Innovative Drug Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Innovative Drug Players by Market Size
  3.1.1 Global Top Innovative Drug Players by Revenue (2015-2020)
  3.1.2 Global Innovative Drug Revenue Market Share by Players (2015-2020)
  3.1.3 Global Innovative Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Innovative Drug Market Concentration Ratio
  3.2.1 Global Innovative Drug Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Innovative Drug Revenue in 2019
3.3 Innovative Drug Key Players Head office and Area Served
3.4 Key Players Innovative Drug Product Solution and Service
3.5 Date of Enter into Innovative Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Innovative Drug Historic Market Size by Type (2015-2020)
4.2 Global Innovative Drug Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Innovative Drug Market Size by Application (2015-2020)
5.2 Global Innovative Drug Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Innovative Drug Market Size (2015-2020)
6.2 Innovative Drug Key Players in North America (2019-2020)
6.3 North America Innovative Drug Market Size by Type (2015-2020)
6.4 North America Innovative Drug Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Innovative Drug Market Size (2015-2020)
7.2 Innovative Drug Key Players in Europe (2019-2020)
7.3 Europe Innovative Drug Market Size by Type (2015-2020)
7.4 Europe Innovative Drug Market Size by Application (2015-2020)

8 CHINA

8.1 China Innovative Drug Market Size (2015-2020)
8.2 Innovative Drug Key Players in China (2019-2020)
8.3 China Innovative Drug Market Size by Type (2015-2020)
8.4 China Innovative Drug Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Innovative Drug Market Size (2015-2020)
9.2 Innovative Drug Key Players in Japan (2019-2020)
9.3 Japan Innovative Drug Market Size by Type (2015-2020)
9.4 Japan Innovative Drug Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Innovative Drug Market Size (2015-2020)
10.2 Innovative Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Innovative Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Innovative Drug Market Size by Application (2015-2020)

11 INDIA

11.1 India Innovative Drug Market Size (2015-2020)
11.2 Innovative Drug Key Players in India (2019-2020)
11.3 India Innovative Drug Market Size by Type (2015-2020)
11.4 India Innovative Drug Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Innovative Drug Market Size (2015-2020)
12.2 Innovative Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Innovative Drug Market Size by Type (2015-2020)
12.4 Central & South America Innovative Drug Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Innovative Drug Introduction
  13.1.4 Pfizer Revenue in Innovative Drug Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Innovative Drug Introduction
  13.2.4 Roche Revenue in Innovative Drug Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Sanofi
  13.3.1 Sanofi Company Details
  13.3.2 Sanofi Business Overview and Its Total Revenue
  13.3.3 Sanofi Innovative Drug Introduction
  13.3.4 Sanofi Revenue in Innovative Drug Business (2015-2020)
  13.3.5 Sanofi Recent Development
13.4 Johnson & Johnson
  13.4.1 Johnson & Johnson Company Details
  13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.4.3 Johnson & Johnson Innovative Drug Introduction
  13.4.4 Johnson & Johnson Revenue in Innovative Drug Business (2015-2020)
  13.4.5 Johnson & Johnson Recent Development
13.5 Merck & Co. (MSD)
  13.5.1 Merck & Co. (MSD) Company Details
  13.5.2 Merck & Co. (MSD) Business Overview and Its Total Revenue
  13.5.3 Merck & Co. (MSD) Innovative Drug Introduction
  13.5.4 Merck & Co. (MSD) Revenue in Innovative Drug Business (2015-2020)
  13.5.5 Merck & Co. (MSD) Recent Development
13.6 Novartis
  13.6.1 Novartis Company Details
  13.6.2 Novartis Business Overview and Its Total Revenue
  13.6.3 Novartis Innovative Drug Introduction
  13.6.4 Novartis Revenue in Innovative Drug Business (2015-2020)
  13.6.5 Novartis Recent Development
13.7 AbbVie
  13.7.1 AbbVie Company Details
  13.7.2 AbbVie Business Overview and Its Total Revenue
  13.7.3 AbbVie Innovative Drug Introduction
  13.7.4 AbbVie Revenue in Innovative Drug Business (2015-2020)
  13.7.5 AbbVie Recent Development
13.8 Gilead Sciences
  13.8.1 Gilead Sciences Company Details
  13.8.2 Gilead Sciences Business Overview and Its Total Revenue
  13.8.3 Gilead Sciences Innovative Drug Introduction
  13.8.4 Gilead Sciences Revenue in Innovative Drug Business (2015-2020)
  13.8.5 Gilead Sciences Recent Development
13.9 GlaxoSmithKline (GSK)
  13.9.1 GlaxoSmithKline (GSK) Company Details
  13.9.2 GlaxoSmithKline (GSK) Business Overview and Its Total Revenue
  13.9.3 GlaxoSmithKline (GSK) Innovative Drug Introduction
  13.9.4 GlaxoSmithKline (GSK) Revenue in Innovative Drug Business (2015-2020)
  13.9.5 GlaxoSmithKline (GSK) Recent Development
13.10 Amgen
  13.10.1 Amgen Company Details
  13.10.2 Amgen Business Overview and Its Total Revenue
  13.10.3 Amgen Innovative Drug Introduction
  13.10.4 Amgen Revenue in Innovative Drug Business (2015-2020)
  13.10.5 Amgen Recent Development
13.11 AstraZeneca
  10.11.1 AstraZeneca Company Details
  10.11.2 AstraZeneca Business Overview and Its Total Revenue
  10.11.3 AstraZeneca Innovative Drug Introduction
  10.11.4 AstraZeneca Revenue in Innovative Drug Business (2015-2020)
  10.11.5 AstraZeneca Recent Development
13.12 Bristol-Myers Squibb
  10.12.1 Bristol-Myers Squibb Company Details
  10.12.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  10.12.3 Bristol-Myers Squibb Innovative Drug Introduction
  10.12.4 Bristol-Myers Squibb Revenue in Innovative Drug Business (2015-2020)
  10.12.5 Bristol-Myers Squibb Recent Development
13.13 Eli Lilly
  10.13.1 Eli Lilly Company Details
  10.13.2 Eli Lilly Business Overview and Its Total Revenue
  10.13.3 Eli Lilly Innovative Drug Introduction
  10.13.4 Eli Lilly Revenue in Innovative Drug Business (2015-2020)
  10.13.5 Eli Lilly Recent Development
13.14 Teva
  10.14.1 Teva Company Details
  10.14.2 Teva Business Overview and Its Total Revenue
  10.14.3 Teva Innovative Drug Introduction
  10.14.4 Teva Revenue in Innovative Drug Business (2015-2020)
  10.14.5 Teva Recent Development
13.15 Bayer
  10.15.1 Bayer Company Details
  10.15.2 Bayer Business Overview and Its Total Revenue
  10.15.3 Bayer Innovative Drug Introduction
  10.15.4 Bayer Revenue in Innovative Drug Business (2015-2020)
  10.15.5 Bayer Recent Development
13.16 Novo Nordisk
  10.16.1 Novo Nordisk Company Details
  10.16.2 Novo Nordisk Business Overview and Its Total Revenue
  10.16.3 Novo Nordisk Innovative Drug Introduction
  10.16.4 Novo Nordisk Revenue in Innovative Drug Business (2015-2020)
  10.16.5 Novo Nordisk Recent Development
13.17 Allergan
  10.17.1 Allergan Company Details
  10.17.2 Allergan Business Overview and Its Total Revenue
  10.17.3 Allergan Innovative Drug Introduction
  10.17.4 Allergan Revenue in Innovative Drug Business (2015-2020)
  10.17.5 Allergan Recent Development
13.18 Takeda
  10.18.1 Takeda Company Details
  10.18.2 Takeda Business Overview and Its Total Revenue
  10.18.3 Takeda Innovative Drug Introduction
  10.18.4 Takeda Revenue in Innovative Drug Business (2015-2020)
  10.18.5 Takeda Recent Development
13.19 Boehringer Ingelheim
  10.19.1 Boehringer Ingelheim Company Details
  10.19.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  10.19.3 Boehringer Ingelheim Innovative Drug Introduction
  10.19.4 Boehringer Ingelheim Revenue in Innovative Drug Business (2015-2020)
  10.19.5 Boehringer Ingelheim Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Innovative Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Innovative Drug Revenue
Table 3. Ranking of Global Top Innovative Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Innovative Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biological Medicine
Table 6. Key Players of Chemical Medicine
Table 7. COVID-19 Impact Global Market: (Four Innovative Drug Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Innovative Drug Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Innovative Drug Players to Combat Covid-19 Impact
Table 12. Global Innovative Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Innovative Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Innovative Drug Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Innovative Drug Market Share by Regions (2015-2020)
Table 16. Global Innovative Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Innovative Drug Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Innovative Drug Market Growth Strategy
Table 22. Main Points Interviewed from Key Innovative Drug Players
Table 23. Global Innovative Drug Revenue by Players (2015-2020) (Million US$)
Table 24. Global Innovative Drug Market Share by Players (2015-2020)
Table 25. Global Top Innovative Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Innovative Drug as of 2019)
Table 26. Global Innovative Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Innovative Drug Product Solution and Service
Table 29. Date of Enter into Innovative Drug Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Innovative Drug Market Size by Type (2015-2020) (Million US$)
Table 32. Global Innovative Drug Market Size Share by Type (2015-2020)
Table 33. Global Innovative Drug Revenue Market Share by Type (2021-2026)
Table 34. Global Innovative Drug Market Size Share by Application (2015-2020)
Table 35. Global Innovative Drug Market Size by Application (2015-2020) (Million US$)
Table 36. Global Innovative Drug Market Size Share by Application (2021-2026)
Table 37. North America Key Players Innovative Drug Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Innovative Drug Market Share (2019-2020)
Table 39. North America Innovative Drug Market Size by Type (2015-2020) (Million US$)
Table 40. North America Innovative Drug Market Share by Type (2015-2020)
Table 41. North America Innovative Drug Market Size by Application (2015-2020) (Million US$)
Table 42. North America Innovative Drug Market Share by Application (2015-2020)
Table 43. Europe Key Players Innovative Drug Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Innovative Drug Market Share (2019-2020)
Table 45. Europe Innovative Drug Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Innovative Drug Market Share by Type (2015-2020)
Table 47. Europe Innovative Drug Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Innovative Drug Market Share by Application (2015-2020)
Table 49. China Key Players Innovative Drug Revenue (2019-2020) (Million US$)
Table 50. China Key Players Innovative Drug Market Share (2019-2020)
Table 51. China Innovative Drug Market Size by Type (2015-2020) (Million US$)
Table 52. China Innovative Drug Market Share by Type (2015-2020)
Table 53. China Innovative Drug Market Size by Application (2015-2020) (Million US$)
Table 54. China Innovative Drug Market Share by Application (2015-2020)
Table 55. Japan Key Players Innovative Drug Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Innovative Drug Market Share (2019-2020)
Table 57. Japan Innovative Drug Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Innovative Drug Market Share by Type (2015-2020)
Table 59. Japan Innovative Drug Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Innovative Drug Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Innovative Drug Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Innovative Drug Market Share (2019-2020)
Table 63. Southeast Asia Innovative Drug Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Innovative Drug Market Share by Type (2015-2020)
Table 65. Southeast Asia Innovative Drug Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Innovative Drug Market Share by Application (2015-2020)
Table 67. India Key Players Innovative Drug Revenue (2019-2020) (Million US$)
Table 68. India Key Players Innovative Drug Market Share (2019-2020)
Table 69. India Innovative Drug Market Size by Type (2015-2020) (Million US$)
Table 70. India Innovative Drug Market Share by Type (2015-2020)
Table 71. India Innovative Drug Market Size by Application (2015-2020) (Million US$)
Table 72. India Innovative Drug Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Innovative Drug Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Innovative Drug Market Share (2019-2020)
Table 75. Central & South America Innovative Drug Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Innovative Drug Market Share by Type (2015-2020)
Table 77. Central & South America Innovative Drug Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Innovative Drug Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Product
Table 87. Roche Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 88. Roche Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 93. Sanofi Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Product
Table 97. Johnson & Johnson Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 98. Johnson & Johnson Recent Development
Table 99. Merck & Co. (MSD) Company Details
Table 100. Merck & Co. (MSD) Business Overview
Table 101. Merck & Co. (MSD) Product
Table 102. Merck & Co. (MSD) Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 103. Merck & Co. (MSD) Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. AbbVie Company Details
Table 110. AbbVie Business Overview
Table 111. AbbVie Product
Table 112. AbbVie Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 113. AbbVie Recent Development
Table 114. Gilead Sciences Business Overview
Table 115. Gilead Sciences Product
Table 116. Gilead Sciences Company Details
Table 117. Gilead Sciences Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 118. Gilead Sciences Recent Development
Table 119. GlaxoSmithKline (GSK) Company Details
Table 120. GlaxoSmithKline (GSK) Business Overview
Table 121. GlaxoSmithKline (GSK) Product
Table 122. GlaxoSmithKline (GSK) Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 123. GlaxoSmithKline (GSK) Recent Development
Table 124. Amgen Company Details
Table 125. Amgen Business Overview
Table 126. Amgen Product
Table 127. Amgen Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 128. Amgen Recent Development
Table 129. AstraZeneca Company Details
Table 130. AstraZeneca Business Overview
Table 131. AstraZeneca Product
Table 132. AstraZeneca Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 133. AstraZeneca Recent Development
Table 134. Bristol-Myers Squibb Company Details
Table 135. Bristol-Myers Squibb Business Overview
Table 136. Bristol-Myers Squibb Product
Table 137. Bristol-Myers Squibb Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 138. Bristol-Myers Squibb Recent Development
Table 139. Eli Lilly Company Details
Table 140. Eli Lilly Business Overview
Table 141. Eli Lilly Product
Table 142. Eli Lilly Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 143. Eli Lilly Recent Development
Table 144. Teva Company Details
Table 145. Teva Business Overview
Table 146. Teva Product
Table 147. Teva Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 148. Teva Recent Development
Table 149. Bayer Company Details
Table 150. Bayer Business Overview
Table 151. Bayer Product
Table 152. Bayer Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 153. Bayer Recent Development
Table 154. Novo Nordisk Company Details
Table 155. Novo Nordisk Business Overview
Table 156. Novo Nordisk Product
Table 157. Novo Nordisk Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 158. Novo Nordisk Recent Development
Table 159. Allergan Company Details
Table 160. Allergan Business Overview
Table 161. Allergan Product
Table 162. Allergan Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 163. Allergan Recent Development
Table 164. Takeda Company Details
Table 165. Takeda Business Overview
Table 166. Takeda Product
Table 167. Takeda Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 168. Takeda Recent Development
Table 169. Boehringer Ingelheim Company Details
Table 170. Boehringer Ingelheim Business Overview
Table 171. Boehringer Ingelheim Product
Table 172. Boehringer Ingelheim Revenue in Innovative Drug Business (2015-2020) (Million US$)
Table 173. Boehringer Ingelheim Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Innovative Drug Market Share by Type: 2020 VS 2026
Figure 2. Biological Medicine Features
Figure 3. Chemical Medicine Features
Figure 4. Global Innovative Drug Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Others Case Studies
Figure 8. Innovative Drug Report Years Considered
Figure 9. Global Innovative Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Innovative Drug Market Share by Regions: 2020 VS 2026
Figure 11. Global Innovative Drug Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Innovative Drug Market Share by Players in 2019
Figure 14. Global Top Innovative Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Innovative Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Innovative Drug Revenue in 2019
Figure 16. North America Innovative Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Innovative Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Innovative Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Innovative Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Innovative Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Innovative Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Innovative Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Johnson & Johnson Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 31. Merck & Co. (MSD) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck & Co. (MSD) Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AbbVie Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 37. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Gilead Sciences Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 39. GlaxoSmithKline (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline (GSK) Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 41. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Amgen Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 43. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. AstraZeneca Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 45. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 47. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Eli Lilly Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 49. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Teva Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bayer Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 53. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novo Nordisk Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 55. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Allergan Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 57. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Takeda Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 59. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Innovative Drug Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed